Literature DB >> 6385608

The prevalence of cataract in insulin-dependent and non-insulin-dependent-diabetes mellitus.

N V Nielsen, T Vinding.   

Abstract

In an epidemiological study of 533 diabetics - 227 treated with insulin and 306 treated with oral hypoglycaemic agents (OHA) - the prevalence of cataract/aphakia and lens opacities was in total higher (P less than 0.01) in type 2 diabetics (= non-insulin-dependent diabetes) compared with type 1 diabetics (= insulin-dependent diabetes). Type 2 diabetics were characterized by a higher age than type 1 diabetics (P less than 0.01). Thus, an age-specific comparison between type 1 and type 2 diabetics showed no difference (P greater than 0.05) in the occurrence of cataract/aphakia in type 1 diabetics (P less than 0.01) in the age interval 50-64 years. Cataract/aphakia and lens opacities correlated positively (P less than 0.01) with the current age and presence of retinopathy within both groups of diabetics. In type 1 diabetics the duration of diabetes was related to cataract/aphakia. A comparison of this study with the results of previous population studies of cataract in non-diabetics indicates that cataract/aphakia occurs more frequently in diabetics exclusively below the age of 65-70 years.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6385608     DOI: 10.1111/j.1755-3768.1984.tb03972.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  11 in total

Review 1.  Optical quality of the diabetic eye: a review.

Authors:  A M Calvo-Maroto; R J Perez-Cambrodí; C Albarán-Diego; A Pons; A Cerviño
Journal:  Eye (Lond)       Date:  2014-08-15       Impact factor: 3.775

2.  Visual outcome after phacoemulsification and IOL implantation in diabetic patients.

Authors:  A Zaczek; G Olivestedt; C Zetterström
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

3.  A pilot study on total, corneal, and internal aberrations in insulin-dependent and non-insulin-dependent diabetes mellitus patients.

Authors:  Ana M Calvo-Maroto; Rafael J Pérez-Cambrodí; Santiago García-Lázaro; César Albarrán-Diego; Alejandro Cerviño
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-25       Impact factor: 3.117

4.  High sugar-induced repression of antioxidant and anti-apoptotic genes in lens: reversal by pyruvate.

Authors:  Shambhu D Varma; Krish Chandrasekaran
Journal:  Mol Cell Biochem       Date:  2015-02-25       Impact factor: 3.396

5.  Diabetic cataract-pathogenesis, epidemiology and treatment.

Authors:  Andreas Pollreisz; Ursula Schmidt-Erfurth
Journal:  J Ophthalmol       Date:  2010-06-17       Impact factor: 1.909

6.  The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial.

Authors:  Morteza Entezari; Alireza Ramezani; Homayon Nikkhah; Mehdi Yaseri
Journal:  Int Ophthalmol       Date:  2016-03-14       Impact factor: 2.031

7.  The transparency of the lens: a comparison between diabetic and non-diabetic patients.

Authors:  S L Franklin; J Flammer; R De Natale; C Rutishuser
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

Review 8.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

9.  Changes in the tear proteins of diabetic patients.

Authors:  F H Grus; P Sabuncuo; H B Dick; A J Augustin; N Pfeiffer
Journal:  BMC Ophthalmol       Date:  2002-10-31       Impact factor: 2.209

10.  LncRNA MALAT1 Regulates miR-144-3p to Facilitate Epithelial-Mesenchymal Transition of Lens Epithelial Cells via the ROS/NRF2/Notch1/Snail Pathway.

Authors:  Wei Ye; Jiyuan Ma; Fang Wang; Tong Wu; Mengmei He; Ji Li; Rui Pei; Luning Zhang; Yafen Wang; Jian Zhou
Journal:  Oxid Med Cell Longev       Date:  2020-11-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.